Difference between revisions of "Part:BBa K5235010"
A13716990344 (Talk | contribs) |
A13716990344 (Talk | contribs) (→Usage and Biology) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 20: | Line 20: | ||
</p> | </p> | ||
| − | https://static.igem.wiki/teams/5235/ | + | <html> |
| − | + | <div style="text-align:center;"> | |
| + | <img src="https://static.igem.wiki/teams/5235/new/nc30.jpg" width="750" style="display:block; margin:auto;"> | ||
| + | </div style="text-align:center;"> | ||
| + | <caption> | ||
Fig. 1(a) Function of BsAld, CsAlaDC, and GMAS. | Fig. 1(a) Function of BsAld, CsAlaDC, and GMAS. | ||
| + | </caption> | ||
| + | <div> | ||
| + | </div> | ||
| + | </html> | ||
| − | https://static.igem.wiki/teams/5235/ | + | <html> |
| − | + | <div style="text-align:center;"> | |
| + | <img src="https://static.igem.wiki/teams/5235/new/nc31.jpg" width="750" style="display:block; margin:auto;"> | ||
| + | </div style="text-align:center;"> | ||
| + | <caption> | ||
Fig. 1(b) Function of PPK and GNP1 | Fig. 1(b) Function of PPK and GNP1 | ||
| + | </caption> | ||
| + | <div> | ||
| + | </div> | ||
| + | </html> | ||
<p> | <p> | ||
| Line 36: | Line 50: | ||
</p> | </p> | ||
| − | https://static.igem.wiki/teams/5235/engineering/part-circuit.png | + | <html> |
| + | <div style="text-align:center;"> | ||
| + | <img src="https://static.igem.wiki/teams/5235/engineering/part-circuit.png" width="750" style="display:block; margin:auto;"> | ||
| + | </div> | ||
| + | </html> | ||
Fig. 2 Gene circuit for expression of this part in E. coli. | Fig. 2 Gene circuit for expression of this part in E. coli. | ||
| Line 52: | Line 70: | ||
</p> | </p> | ||
| − | https://static.igem.wiki/teams/5235/ | + | <html> |
| + | <div style="text-align:center;"> | ||
| + | <img src="https://static.igem.wiki/teams/5235/new/nc6.jpg" width="750" style="display:block; margin:auto;"> | ||
| + | </div> | ||
| + | </html> | ||
Fig. 3 HPLC results verified the successful production of L-Theanine around retention time 2.4s. | Fig. 3 HPLC results verified the successful production of L-Theanine around retention time 2.4s. | ||
Latest revision as of 12:35, 2 October 2024
GMAS-PPK-BsAld-CsAlaDC-GNP1
In 2024, SHSBNU-China aims to use synthetic biology techniques to genetically edit the E. coli strain BL21 to produce L-theanine. We designed a plasmid containing five genes (BsAld, CsAlaDC, GMAS, PPK, and GNP1) responsible for the production and transport of theanine on the common vector pET28a. The plasmid is designed to be expression in E. coli with IPTG controlled induction, followed by HP-LC testing of the supernatant to determine the yield.
We used five genes in total: BsAld, CsAlaDC, GMAS, PPK, and GNP1. - BsAld, CsAlaDC, and GMAS are responsible for the de novo synthesis of theanine, starting from glucose. BsAld and CsAlaDC carry out the conversion of pyruvate to ethylamine, and GMAS synthesizes theanine from ethylamine and glutamate, which is produced by the generic bacterial TCA cycle. - PPK provides ATP to aid the synthesis pathway. - GNP1 is responsible for transporting the synthesized theanine out of the bacterial cells.
Usage and Biology
by SHSBNU-China 2024
In 2024, SHSBNU-China aims to use synthetic biology techniques to genetically edit the E. coli strain BL21 to produce L-Theanine. L-theanine is a non-protein amino acid found in tea leaves that can be used to alleviate anxiety and improve sleep quality. We designed a plasmid containing five genes (BsAld, CsAlaDC, GMAS, PPK, and GNP1) responsible for the production and transport of theanine on the common vector pET28a. The plasmid is designed to be expression in E. coli with IPTG controlled induction, followed by HP-LC testing of the supernatant to determine the yield.
This composite part is composed of five basic parts: BsAld, CsAlaDC, GMAS, PPK, and GNP1. - BsAld, CsAlaDC, and GMAS are responsible for the de novo synthesis of theanine, starting from glucose. BsAld and CsAlaDC carry out the conversion of pyruvate to ethylamine, and GMAS synthesizes theanine from ethylamine and glutamate, which is produced by the generic bacterial TCA cycle. - PPK provides ATP to aid the synthesis pathway. - GNP1 is responsible for transporting the synthesized theanine out of the bacterial cells.
Fig. 2 Gene circuit for expression of this part in E. coli.
We controlled the expression of the enzymes with one single T7 promoter, aided with a lac operator (LacO), all carried on a pET28a vector. Each part has its own RBS (part B0034), but all connected in series and controlled by a common T7 promoter. The plasmid was transformed into E. coli (BL21). The bacteria strains were first cultured in normal LB medium with proper antibiotics till the OD600 reached 0.6 - 0.8. Then, centrifuge at 4000 rpm for 5 minutes to collect the bacteria, resuspend in the special fermentation medium, add 0.3 mM IPTG to induce enzyme expression, and culture at 30°C with 220 rpm for 24 hours.
Fermentation medium: 10 g/L tryptone, 5 g/L yeast extract, 10 mmol/L MgCl2·6H2O, 150 mmol/L (NaPO3)6, 0 - 20g/L glucose.
Centrifuge the fermented broth at 12,000 rpm, and collect the supernatant.
Fig. 3 HPLC results verified the successful production of L-Theanine around retention time 2.4s.
In the HPLC data, the standard L-Theanine sample used analytical grade L-Theanine purchased from Aladdin Chemicals with greater than 98% purity. The standard sample solution was prepared at a concentration of 200mg/L. The HPLC result showed a single peak of standard L-Theanine around retention time 2.4s. The control group was prepared using the E. coli culture with the correct expression plasmid, but with no iPTG induction, nor added glucose. There is a small hump observed in the HPLC results for the control group, suggesting possible leaking expression of the designed enzymes. For the sample group, proper iPTG induction was conducted at OD600 around 0.6 – 0.8, and 15g/L glucose was added. The HPLC result demonstrated a clear rising around retention time 2.4s, indicating the production of L-Theanine.
Fig. 4 Three-point standard curve from L-Theanine HPLC, and we estimated the yield of our bacteria culture can reach 38.8 mg/L when adding 15g/L glucose to the substrate medium.
The yield results estimated from HPLC indicated that the L-Theanine yield from E. coli fermentation has a noticeable dependence on the input of glucose. This is reasonable since the current synthesis pathway requires two key intermediates that both rely on conversion from glucose. In the future, we will explore more fermentation conditions of using two different carbon sources in the substrate medium to increase L-Theanine production yield, as well as to explore other fermentation optimizations such as better enzymes from other species.
References
[1] Cao, R., Hu, S., Lu, Y., Wang, W., Fu, Z., & Cheng, J. (2023). Fermentative Production of L-Theanine in Escherichia coli via the Construction of an Adenosine Triphosphate Regeneration System. Fermentation, 9(10), 875–875.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]